imipramine has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 11 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pretreatment of rotenone groups with AMI or IMI prevented rotenone-induced neuronal degeneration and increased striatal dopamine level with motor recovery." | 1.43 | Imipramine and amitriptyline ameliorate the rotenone model of Parkinson's disease in rats. ( Abdelkader, NF; El-Sayeh, BM; Kandil, EA; Saleh, S, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (81.82) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, KS | 2 |
| Kang, YM | 1 |
| Kang, Y | 1 |
| Park, TS | 1 |
| Park, HY | 1 |
| Kim, YJ | 1 |
| Han, BS | 1 |
| Kim, CH | 1 |
| Lee, CH | 1 |
| Ardayfio, PA | 1 |
| Han, PL | 1 |
| Jung, BH | 1 |
| Kandil, EA | 1 |
| Abdelkader, NF | 1 |
| El-Sayeh, BM | 1 |
| Saleh, S | 1 |
| DENMARK, JC | 1 |
| DAVID, JD | 1 |
| McCOMB, SG | 1 |
| PAKKENBERG, H | 1 |
| GILLINGHAM, FJ | 2 |
| KALYANARAMAN, S | 1 |
| BOHACEK, N | 1 |
| HAJNSEK, F | 1 |
| SARTORIUS, N | 1 |
| BARUK, H | 1 |
| LAUNAY, J | 1 |
| SEGERS, J | 1 |
| SCHUNZELAAR, K | 1 |
| NUYTS, SA | 1 |
| SMYTHIES, JR | 1 |
| STRANG, RR | 1 |
| LIM, H | 1 |
| TAN, K | 1 |
11 other studies available for imipramine and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Pitx3 deficient mice as a genetic animal model of co-morbid depressive disorder and parkinsonism.
Topics: Anhedonia; Animals; Antidepressive Agents; Brain; Comorbidity; Corticosterone; Depressive Disorder; | 2014 |
Imipramine and amitriptyline ameliorate the rotenone model of Parkinson's disease in rats.
Topics: Amitriptyline; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Antiparkinson Agents; | 2016 |
Imipramine hydrochloride (Tofranil) in Parkinsonism. A preliminary report.
Topics: Imipramine; Parkinson Disease; Parkinsonian Disorders; Psychopharmacology | 1961 |
[Pathogenesis and medical treatment of parkinsonism].
Topics: Humans; Imipramine; Parkinson Disease; Parkinsonian Disorders; Piperidines; Trihexyphenidyl | 1963 |
PARKINSON'S DISEASE.
Topics: Amitriptyline; Dextroamphetamine; Humans; Imipramine; Muscle Relaxants, Central; Neurosurgery; Orphe | 1963 |
[EXTRAPYRAMIDAL SYMPTOMS DUE TO THE USE OF PSYCHOPHARMACA].
Topics: Chlorpromazine; Chlorprothixene; Extrapyramidal Tracts; Fluphenazine; Imipramine; Methotrimeprazine; | 1963 |
[NEUROLEPTICS AND THE LAW OF STAGES].
Topics: Antipsychotic Agents; Catalepsy; Catatonia; Chlorpromazine; Epilepsy; Humans; Imipramine; Parkinsoni | 1964 |
REPORT ON THE TREATMENT OF PSYCHOTIC PATIENTS WITH SORDINOL.
Topics: Adolescent; Clopenthixol; Humans; Imipramine; Parkinsonian Disorders; Psychotic Disorders; Schizophr | 1964 |
A CASE OF POSTENCEPHALITIC PARKINSONISM RESPONDING TO COMBINED SURGICAL AND MEDICINAL TREATMENT.
Topics: Amitriptyline; Chlordiazepoxide; Depression; Depressive Disorder; Drug Therapy; Encephalitis; Eye Mo | 1965 |
IMIPRAMINE IN TREATMENT OF PARKINSONISM: A DOUBLE-BLIND PLACEBO STUDY.
Topics: Biomedical Research; Double-Blind Method; Drug Therapy; Imipramine; Parkinsonian Disorders; Placebos | 1965 |
[Treatment of Parkinson syndroms with tofranil].
Topics: Humans; Imipramine; Parkinson Disease; Parkinsonian Disorders | 1961 |